Claims for Patent: 9,084,439

Summary for Patent: 9,084,439

Title:	Translucent smokeless tobacco product
Abstract:	The invention provides a smokeless tobacco product comprising a tobacco extract. In some embodiments, the smokeless tobacco product is translucent. The invention further provides methods for making and using the smokeless tobacco product. In certain embodiments, the smokeless tobacco product comprises isomalt, maltitol syrup, and a translucent tobacco extract prepared by ultrafiltration.
Inventor(s):	Holton, Jr.; Darrell (Clemmons, NC)
Assignee:	R.J. Reynolds Tobacco Company (Winston-Salem, NC)
Application Number:	13/240,525
Patent Claims:	1. A smokeless tobacco product comprising: a. a tobacco extract in an amount of at least about 3% by weight, wherein the tobacco extract is an ultrafiltered tobacco extract characterized as translucent or transparent and consists of compounds having a molecular weight of less than about 50,000 Da; b. a sugar substitute in an amount of at least about 80% by weight, wherein the sugar substitute is a non-hygroscopic sugar alcohol capable of forming a glassy matrix; and c. a sugar alcohol syrup, wherein the smokeless tobacco product is translucent. 2. The smokeless tobacco product of claim 1, wherein the sugar substitute is isomalt. 3. The smokeless tobacco product of claim 1, wherein the sugar substitute is present in an amount of at least about 84% by weight. 4. The smokeless tobacco product of claim 1, wherein the sugar substitute is present in an amount of at least about 90% by weight. 5. The smokeless tobacco product of claim 1, wherein the sugar alcohol syrup is maltitol syrup. 6. The smokeless tobacco product of claim 1, wherein the tobacco extract is a heat-treated tobacco extract that has been treated prior to inclusion in the smokeless tobacco product by heating the tobacco extract in an aqueous solution comprising L-lysine, L-cysteine, asparaginase, or hydrogen peroxide. 7. The smokeless tobacco product of claim 6, wherein the aqueous solution further comprises NaOH. 8. The smokeless tobacco product of claim 1, wherein the tobacco extract is a heat-treated tobacco extract that has been treated prior to inclusion in the smokeless tobacco product by heating the tobacco extract in an aqueous solution comprising L-lysine and NaOH. 9. The smokeless tobacco product of claim 1, wherein the tobacco extract consists of compounds having a molecular weight of less than about 5,000 Da. 10. The smokeless tobacco product of claim 1, further comprising one or more flavorants. 11. The smokeless tobacco product of claim 10, wherein the amount of flavorant is from about 0.1 to about 0.5 percent by weight of the smokeless tobacco product. 12. The smokeless tobacco product of claim 10, wherein the flavorant is vanillin or mint flavor. 13. The smokeless tobacco product of claim 1, further comprising at least one sweetener. 14. The smokeless tobacco product of claim 13, wherein the at least one sweetener comprises sucralose. 15. The smokeless tobacco product of claim 1, further comprising NaCl. 16. The smokeless tobacco product of claim 15, wherein the amount of NaCl is from about 0.5 to about 1 percent by weight of the smokeless tobacco product. 17. A translucent smokeless tobacco product comprising: a. a translucent or transparent tobacco extract consisting of components having a molecular weight of no more than about 50,000 Da in an amount of at least about 3% by weight; b. a non-hygroscopic sugar alcohol capable of forming a glassy matrix in an amount of at least about 80% by weight; and c. a sugar alcohol syrup in an amount sufficient to slow recrystallization of the non-hygroscopic sugar alcohol, wherein the smokeless tobacco product is translucent. 18. A method of preparing the translucent smokeless tobacco product of claim 1, comprising: (i) mixing a translucent or transparent tobacco extract with a non-hygroscopic sugar alcohol capable of forming a glassy matrix in a melted state to form a mixture; and (ii) cooling the mixture to room temperature to form a solid smokeless tobacco product exhibiting translucency. 19. The method of claim 18, wherein the translucent or transparent tobacco extract has been treated by size exclusion chromatography, microfiltration, ultrafiltration, nanofiltration, reverse osmosis, or a combination thereof. 20. The method of claim 19, wherein the treatment removes components having a molecular weight above about 50,000 Da. 21. The method of claim 18, wherein the translucent or transparent tobacco extract has been heat treated by heating the tobacco extract in an aqueous solution comprising L-lysine, L-cysteine, asparaginase, or hydrogen peroxide. 22. The method of claim 21, wherein the aqueous solution further comprises NaOH. 23. The method of claim 21, wherein the heat treating step is conducted at about 88.degree. C. 24. The method of claim 21, wherein the translucent smokeless tobacco product has an acrylamide content of less than about 500 ppb. 25. The method of claim 18, wherein the mixing step comprises heating the non-hygroscopic sugar alcohol to a temperature above the hard crack stage in the absence of the tobacco extract and mixing the tobacco extract into the non-hygroscopic sugar alcohol at a temperature below the hard crack stage. 26. The method of claim 25, wherein the hard crack stage is about 145.degree. C. to about 155.degree. C. and the non-hygroscopic sugar alcohol is heated at a temperature between the hard crack stage and about 171.degree. C. 27. The method of claim 18, further comprising introducing the mixture into molds to create individual product units prior to the cooling step.

Details for Patent 9,084,439

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2039-02-26